Skip to content

13F-HR filed by DC Funds, LP

DC Funds, LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-13 14:00:24 UTC, with 2 holding rows worth $741,464.

Accession
0001398344-26-019986
Filed
2026-11-13
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A combination report, 2 entries on the cover page, a total value of $741,464 stated on the cover page (in dollars after the unit check, H1), rows summing to $741,464 with VALUE read as dollars as filed, 13F file number 028-21338. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
WEREWOLF THERAPEUTICS INC95075A107CMN589,102$543,329dollars as filed
Tscan Therapeutics Inc89854M101COM630,000$198,135dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001398344-26-019986this filing2026-11-13